Log in

600062 China Resources Double-Crane Pharmaceutical Co., Ltd. SSE · China

China Resources Double-Crane Pharmaceutical Co. (600062) news

China Resources Double-Crane Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 600062, recorded under China. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest China Resources Double-Crane Pharmaceutical Co. news

We have not published a story on China Resources Double-Crane Pharmaceutical Co. yet. When there is news, it will appear here.

Questions about China Resources Double-Crane Pharmaceutical Co.

What is the ticker symbol of China Resources Double-Crane Pharmaceutical Co.?

China Resources Double-Crane Pharmaceutical Co., Ltd. trades under the ticker 600062 on SSE.

Where is China Resources Double-Crane Pharmaceutical Co. listed?

China Resources Double-Crane Pharmaceutical Co., Ltd. is listed on SSE.

Which country or territory is China Resources Double-Crane Pharmaceutical Co. listed under?

Our directory records China Resources Double-Crane Pharmaceutical Co., Ltd. under China.

What does China Resources Double-Crane Pharmaceutical Co. do?

Our directory classifies China Resources Double-Crane Pharmaceutical Co., Ltd. as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of China Resources Double-Crane Pharmaceutical Co.?

The ISIN recorded for China Resources Double-Crane Pharmaceutical Co., Ltd. is CNE000000Q94.

Does aibio.space cover China Resources Double-Crane Pharmaceutical Co.?

aibio.space lists China Resources Double-Crane Pharmaceutical Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to China Resources Double-Crane Pharmaceutical Co.?

Companies in our directory listed in the same country and business area as China Resources Double-Crane Pharmaceutical Co.: Zhejiang Xinguang Pharmaceutical Co., Guilin Sanjin Pharmaceutical Co., Shanghai Kaibao Pharmaceutical Co., Sihuan Pharmaceutical Holdings Group, Lanzhou Foci Pharmaceutical Co., Jilin Province Xidian Pharmaceutical Sci-Tech Development Co..

Investor discussion: China Resources Double-Crane Pharmaceutical Co.

Members talk about China Resources Double-Crane Pharmaceutical Co. (600062). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:600062 on TradingView.

Listing details

China Resources Double-Crane Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 600062, recorded under China. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
China Resources Double-Crane Pharmaceutical Co., Ltd.
Ticker
600062
Listing
SSE
Country or territory
China
Business scope
Biopharma / pharmaceutical profile checked
ISIN
CNE000000Q94
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.